Page last updated: 2024-09-05

sch 51048 and fluconazole

sch 51048 has been researched along with fluconazole in 2 studies

Compound Research Comparison

Studies
(sch 51048)
Trials
(sch 51048)
Recent Studies (post-2010)
(sch 51048)
Studies
(fluconazole)
Trials
(fluconazole)
Recent Studies (post-2010) (fluconazole)
7009,3437213,664

Protein Interaction Comparison

ProteinTaxonomysch 51048 (IC50)fluconazole (IC50)
Lanosterol 14-alpha demethylaseCandida albicans SC53140.1296
Cytochrome P450 2C9 Homo sapiens (human)9.21
Sterol 14-alpha demethylaseTrypanosoma cruzi strain CL Brener0.88

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clemons, KV; Homola, ME; Stevens, DA1
Anaissie, EJ; Dignani, MC; Karyotakis, NC1

Other Studies

2 other study(ies) available for sch 51048 and fluconazole

ArticleYear
Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:5

    Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Half-Life; Itraconazole; Mice; Microbial Sensitivity Tests; Triazoles

1995
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred Strains; Neutropenia; Triazoles

1995